Bastide Le Confort Médical SA
EPA:BLC.PA
17.5 (EUR) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 529.755 | 508.031 | 468.3 | 444.073 | 382.706 | 335.73 | 289.05 | 218.109 | 191.85 | 171.167 | 152.131 | 134.05 | 123.573 | 109.131 | 99.952 | 96.793 | 94.841 |
Cost of Revenue
| 482.923 | 174.303 | 161.5 | 163.81 | 131.096 | 114.941 | 103.693 | 75.444 | 67.248 | 60.232 | 53.973 | 49.011 | 45.535 | 41.761 | 38.917 | 37.94 | 35.149 |
Gross Profit
| 46.832 | 333.728 | 306.8 | 280.263 | 251.61 | 220.789 | 185.357 | 142.665 | 124.602 | 110.935 | 98.158 | 85.039 | 78.038 | 67.37 | 61.035 | 58.853 | 59.692 |
Gross Profit Ratio
| 0.088 | 0.657 | 0.655 | 0.631 | 0.657 | 0.658 | 0.641 | 0.654 | 0.649 | 0.648 | 0.645 | 0.634 | 0.632 | 0.617 | 0.611 | 0.608 | 0.629 |
Reseach & Development Expenses
| 0 | 0.041 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 74.968 | 69.785 | 63.938 | 59.859 | 0 | 0 | 0 | 0 | 0 | 0 | 25.607 | 23.053 | 0 | 19.523 | 16.974 |
Selling & Marketing Expenses
| 0 | 0 | 132.449 | 119.174 | 106.247 | 95.714 | 0 | 0 | 0 | 0 | 0 | 0 | 25.607 | 0 | 0 | 0 | 0 |
SG&A
| 2.061 | 229.678 | 207.417 | 188.959 | 170.185 | 155.573 | 128.229 | 99.56 | 88.105 | 78.592 | 69.78 | 61.572 | 25.607 | 23.053 | 0 | 19.523 | 16.974 |
Other Expenses
| 0.147 | -2.161 | -2.548 | -2.686 | -0.574 | 0.699 | -3.721 | -2.49 | -1.27 | 0 | 0 | 0 | 19.178 | 37.763 | 54.823 | 34.784 | 32.863 |
Operating Expenses
| 1.914 | 294.37 | 275.581 | 251.189 | 223.467 | 202.057 | 168.662 | 131.497 | 110.807 | 98.082 | 87.91 | 76.496 | 70.392 | 60.816 | 54.823 | 54.307 | 49.837 |
Operating Income
| 44.222 | 42.821 | 38.934 | 37.503 | 33.691 | 27.395 | 19.305 | 11.901 | 13.796 | 13.086 | 11.029 | 8.625 | 7.647 | 6.554 | 6.212 | 4.546 | 9.855 |
Operating Income Ratio
| 0.083 | 0.084 | 0.083 | 0.084 | 0.088 | 0.082 | 0.067 | 0.055 | 0.072 | 0.076 | 0.072 | 0.064 | 0.062 | 0.06 | 0.062 | 0.047 | 0.104 |
Total Other Income Expenses Net
| -27.72 | -20.056 | -17.919 | -17.334 | -13.409 | -16.1 | -7.748 | -3.762 | -2.054 | -2.201 | -2.481 | -1.553 | -1.373 | -1.015 | -1.145 | -1.016 | -0.822 |
Income Before Tax
| 16.502 | 22.765 | 21.015 | 20.169 | 20.282 | 11.295 | 11.557 | 8.139 | 11.742 | 10.885 | 8.548 | 7.072 | 6.273 | 5.539 | 5.067 | 3.53 | 9.033 |
Income Before Tax Ratio
| 0.031 | 0.045 | 0.045 | 0.045 | 0.053 | 0.034 | 0.04 | 0.037 | 0.061 | 0.064 | 0.056 | 0.053 | 0.051 | 0.051 | 0.051 | 0.036 | 0.095 |
Income Tax Expense
| 7.015 | 5.96 | 5.928 | 5.822 | 7.67 | 4.911 | 4.056 | 2.63 | 4.524 | 3.885 | 3.324 | 2.87 | 2.695 | 2.309 | 2.212 | 1.286 | 3.144 |
Net Income
| -0.9 | 16.066 | 13.681 | 13.452 | 11.6 | 4.568 | 7.158 | 5.425 | 7.184 | 6.8 | 5.115 | 4.133 | 3.517 | 3.198 | 2.855 | 2.244 | 5.889 |
Net Income Ratio
| -0.002 | 0.032 | 0.029 | 0.03 | 0.03 | 0.014 | 0.025 | 0.025 | 0.037 | 0.04 | 0.034 | 0.031 | 0.028 | 0.029 | 0.029 | 0.023 | 0.062 |
EPS
| -0.12 | 2.02 | 1.96 | 1.83 | 1.58 | 0.62 | 0.98 | 0.74 | 0.98 | 0.93 | 0.7 | 0.56 | 0.48 | 0.44 | 0.39 | 0.31 | 0.8 |
EPS Diluted
| -0.12 | 2.02 | 1.96 | 1.83 | 1.58 | 0.62 | 0.98 | 0.74 | 0.98 | 0.93 | 0.7 | 0.56 | 0.48 | 0.44 | 0.39 | 0.31 | 0.8 |
EBITDA
| 110.324 | 82.363 | 79.51 | 72.77 | 66.668 | 63.555 | 49.421 | 36.384 | 35.016 | 31.91 | 26.825 | 22.007 | 19.508 | 17.073 | 15.88 | 13.898 | 18.083 |
EBITDA Ratio
| 0.208 | 0.162 | 0.17 | 0.164 | 0.174 | 0.189 | 0.171 | 0.167 | 0.183 | 0.186 | 0.176 | 0.164 | 0.158 | 0.156 | 0.159 | 0.144 | 0.191 |